Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
Saved in:
| Title: | Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. |
|---|---|
| Authors: | Strizki JM; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Gaspar JM; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Howe JA; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Hutchins B; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Mohri H; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA., Nair MS; Aaron Diamond AIDS Research Center, Columbia University Medical Center , New York, New York, USA., Kinek KC; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., McKenna P; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Goh SL; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA., Murgolo N; Merck Research Laboratories (MRL), Merck & Co., Inc. , Rahway, New Jersey, USA. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0095323. Date of Electronic Publication: 2023 Dec 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
